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INTRODUCTION 
Biofilms are widely distributed in the natural world such 
as dental plaques, water pipes and congregates in flowing 
water bodies.
1
 Biofilm can form on both biotic and 
abiotic surfaces such as catheters, artificial valves, 
contact lenses and other types of implants. Similarly, 
clinical conditions such as chronic wounds, osteomyelitis, 
periodontitis and chronic otitis media also develop 
biofilm, even in the absence of any foreign device.
2,3
 
Clinically, the biofilm mode of bacterial growth is more 
important than free-floating bacterial colonization or 
infection as this is more tolerant to antimicrobials.
4
 
Recent studies have indicated the role of biofilm in 
chronic wound development and persistence.
5 
Stoodley has defined the biofilm as a “sessile community 
of bacteria that are irreversibly attached to a surface or to 
each other, live in clusters embedded within a matrix of 
extracellular polymeric substance that they have 
ABSTRACT 
Background: The role of microbes in the persistence of chronic wounds is very 
important. Biofilm mode of bacterial growth has been found to be clinically 
very important in various types of infections. Bacterial growth in the form of 
biofilm is now being considered as a strong and effective mechanism of 
bacterial survival and growth in chronic wounds. Therefore it is clinically 
important to further investigate and determine the bacterial groups involved in 
the formation of biofilm in wounds and their mechanism of interference with 
the normal healing process. 
Methods: This study focussed on determining the presence of S. epidermidis 
ica genes, which are responsible for biofilm production by this species. We 
investigated the presence of these genes in skin, blood and wound samples. In 
total, 296 samples were tested for the presence of the ica genes. RT-PCR and 
conventional PCR testing was performed on these samples from different 
sources. 
Results: Our results show that there is presence of a significant number of ica 
positive samples both in skin and blood specimens while only a very small 
percentage of ica positive samples present in chronic non-healing wound 
samples. 
Conclusions: Presence of ica genes in blood samples indicate involvement of 
ica positive S. epidermidis in the case of blood infection. In chronic wound 
samples, there is a small percentage of samples positive for these genes thus 
biofilm producing bacteria other than S. epidermidis are likely to be more 
important in the case of chronic wounds. 
 
Keywords: Biofilm, Chronic wounds, Ica genes, Septicaemia, S. epidermidis  
DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20171079 
 
 
 
1
Infection and Immunity 
Program, Institute of Health and 
Biomedical Innovation, 
Queensland University of 
Technology (QUT), Brisbane, 
Australia 
2
Wound Management 
Innovation Co-operative 
Research Centre, Brisbane, 
Australia 
 
Received: 20 October 2016 
Accepted: 17 November 2016 
 
*Correspondence to: 
Dr. Flavia Huygens, 
Email: f.huygens@qut.edu.au 
 
Copyright: © the author(s), 
publisher and licensee Medip 
Academy. This is an open-
access article distributed under 
the terms of the Creative 
Commons Attribution Non-
Commercial License, which 
permits unrestricted non-
commercial use, distribution, 
and reproduction in any 
medium, provided the original 
work is properly cited. 
Hussain MA et al. Int J Basic Clin Pharmacol. 2017 Apr;6(4):726-733 
                                                          
                 
            International Journal of Basic & Clinical Pharmacology | April 2017 | Vol 6 | Issue 4    Page 727 
produced, and exhibit an altered phenotype with respect 
to gene transcription”.6 Multiple species of bacteria reside 
in a synergistic manner in the form of a biofilm and 
contribute to produce a subclinical and prolonged 
infection.
7
 Biofilms mainly consist of bacteria and 
extracellular polymeric substance (EPS) produced by 
these bacteria to form a complex three dimensional 
structure. Bacteria usually constitute 5-25% of a biofilm’s 
overall structure, while 75-95% is made up of EPS.
2,8 
Biofilm development is a complex process which 
involves many metabolic chemicals, environmental 
signals and substances, and signal transduction 
pathways.
9
 Attachment, maturation and dispersal have 
been described as stages of biofilm development. The 
initial attachment stage involves attachment of planktonic 
bacteria and utilizes chemicals and proteins (adhesins) 
originating from both the host and bacteria.
10
 The second 
stage of maturation consists of bacterial growth along 
with EPS production. Substances present in EPS play a 
vital role in attaching these bacteria to host surfaces as 
well as to each other. Different substances such as 
proteins, lipids, polysaccharides and nucleic acids are the 
main components of EPS.
11,12
 Finally, cells from biofilm 
growth detach and disperse. This final stage is important 
in disease transmission and survival.
10
  
Indwelling devices, biofilm and septicaemia 
Biofilm is a very useful and powerful factor contributing 
to device related infections.
13
 Initial adhesion and 
aggregation of microbes onto multiple layers is followed 
by biofilm formation. There is a view that before the 
actual process of biofilm development and formation, the 
surfaces of indwelling devices are “conditioned” in vivo. 
Different components present in body secretions such as 
saliva, mucus and urine form a coat by adsorbing on the 
surfaces of devices to form a conditioning layer or film 
upon which actual bacterial growth and biofilm formation 
occurs.
 14
 This conditioning film acts as an attaching 
surface for bacteria.
15
 Another view is that this primary 
adhesion is dependent on the chemistry of the material 
used for implanted devices, which also affects other 
processes including biofilm formation and its thickness.
16
 
Dunne has described other factors such as electrostatic 
and hydrophobic interactions, Van der Walls forces and 
temperature that also impact on biofilm formation.
17
 
Biofilms play a vital role in pathogenesis and plays a 
significant part in morbidity and mortality in device 
related infections and resulting septicaemia.
18,19 
The role of biofilms in chronic wound prognosis 
Clinicians treating wound infections are now considering 
biofilm as a major factor in non-healing wounds and 
staphylococci are the commonest bacteria present on 
wound surfaces.
20-22 
In describing the role of biofilm in 
chronic wounds, Bowler have defined it as “communities 
of microorganisms attached to a surface (e.g. wound 
tissue, wound dressings), embedded within a hydrated 
matrix of extracellular polymeric substances (EPS; or 
slime), that provides protection against antimicrobial 
agents and host defences”.20 The presence of biofilm 
typically presents with progressive infections which are 
resistant to antibiotics and immune system 
eradication.
19,23 
Most of the routine treatment methods 
fail in the presence of biofilm.
24
 Although the physical 
removal of biofilm is important, it can quickly reform 
within hours. Hence, it is very important to avoid the 
biofilm reforming by applying appropriate wound 
dressing, debridement and antibiotics.
25
  
James and colleagues found a significant difference in 
acute and chronic wounds in terms of biofilm presence, 
reporting 6% and 60% positivity, respectively.
26
 
However, the precise role of biofilm in chronic wounds is 
not known. One proposed mechanism for interference of 
biofilm with wound healing is by prolonging the 
inflammatory phase of wound healing, which is also 
called sustained hyper-inflammation. This sustained 
inflammation maintains a continuous supply of exudates 
in the wound bed which maintains continuous feeding 
requirements of biofilm forming bacteria.
27
  
In a recent in vitro study by Gawande and co-workers, 
they found that a therapeutic plan involving the 
breakdown of preformed biofilm and inhibiting its 
formation or regrowth, along with broad-spectrum 
antimicrobial therapy, is an effective method to treat 
biofilm related infections.
23
 Diagnosis and confirmation 
of biofilm presence in chronic wounds is very important 
and requires further investigation.
20,28
 Biofilm impaired 
wound healing might be treated more successfully if we 
understand how the innate immune system is affected, 
followed by an approach to target biofilm for the 
treatment of chronic wounds.
29
  
Staphylococci and ica genes 
Staphylococci are known to produce biofilm.
30,31
 
Coagulase-negative staphylococci (CoNS) such as S. 
epidermidis can cause serious hospital acquired infections 
and is a biofilm producing species.
32
 Most common 
victims of S. epidermidis infection are premature 
newborns, patients with leukaemia, intravenous drug 
abuse, other malignancies and patients with indwelling 
polymer bodies, such as prosthetic devices or intravenous 
catheters.
33,34
 
The extracellular Polysaccharide Adhesins (PSA) is a 
significant virulence determinant and is required for 
biofilm formation and adhesion, which is encoded by the 
ica operon, and is subjected to phase variable regulation, 
and an on and off switching mechanism.
35
 Polysaccharide 
intercellular adhesin (PIA) is the main component 
involved in intercellular adhesion by staphylococci.
32,36
 
Stevens et al studied various protein components 
including PIA of biofilm in S. epidermidis and have 
suggested that PIA has a primary role in biofilm 
positivity while protein components contribute 
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significantly towards the maturation of the biofilm.
37,38
 
PIA synthesis requires the presence of the ica operon 
because the enzymes which are involved in its synthesis 
are controlled by the intercellular adhesion operon (ica 
ADBC).
37,38
 Biofilm studies have used oral biofilm as 
research models for some time and its characteristics and 
pathogenesis have been studied. On the other hand, recent 
studies have indicated the role of biofilm in chronic 
wound development and persistence.
5,20,21,39
 
Understanding the role of biofilm and determination of its 
relation to wound chronicity will be very beneficial in 
terms of wound treatment and wound management 
strategies.
9 
Bacterial colonization in the form of biofilm is 
associated with delays in wound healing. However, there 
is still a need to investigate the exact role of biofilm in 
delaying wound healing and the development of anti-
biofilm mechanisms to control infections.
40
  
This study aims to detect of ica genes of S. epidermidis in 
skin, blood and wound samples. We detected a significant 
presence of ica genes in skin as well as in blood samples. 
As wounds are potentially at risk of becoming colonized 
by skin microbes, we tested chronic wound samples for 
the presence of these genes to determine if ica positive S. 
epidermidis is a major biofilm producer in the case of 
chronic non-healing wounds.  
METHODS 
Samples 
Three different types of samples have been included in 
this study: 
1. Swabs were taken from the skin of healthy 
individuals and pure cultures of CoNS strains were 
isolated from these samples.  
2. Coagulase negative staphylococcal isolates 
originating from patients with septicemia. These 
strains were cultured and isolated from patients 
from the Prince Charles (PC) Hospital, Brisbane. 
3. Chronic wound swab samples were obtained from 
the Queensland University of Technology (QUT) 
Wound Clinic, Brisbane. 
Skin swab samples  
Swab samples were collected from the skin of healthy 
individuals (volunteer second and third year 
undergraduate students at QUT). Ethical approval for 
collecting these samples from humans was obtained from 
the QUT Human Research Ethics Committee. In addition, 
written consent was obtained from each participant in the 
study. Skin samples were inoculated on a selective 
medium for staphylococci i.e. Mannitol Salt Agar (MSA). 
Plates were incubated at 37°C for 24 hours. These strains 
were subcultured onto NA plates using the 16-streak 
method. After overnight incubation, the Staphylase test 
(Sigma-Aldrich®, USA) was performed on each of the 
isolates to confirm the coagulase test. Strains that tested 
staphylase-negative were used for further investigation. 
Subsequently, 12-15 colonies from each plate were 
suspended in Lysostaphin solution (200µg/ml; Sigma-
Aldrich, USA) and incubated at 37°C for 30 minutes. 
After 30 minutes of incubation this mixture was ready for 
DNA extraction. 
Hospital septicaemia patient samples 
Patient cultures were acquired from the Prince Charles 
Hospital. The isolates identified as CoNS strains were 
stored on Nutrient Agar (NA) slopes (Biomérieux, 
Australia) at a temperature of 4°C. These strains were 
subcultured onto NA plates using the 16-streak method. 
Plates were incubated at 37°C for 24 hours. After 
overnight incubation, 12-15 colonies were selected from 
each plate and were suspended in 180 µl of Lysostaphin 
solution (200µg/ml). This suspension was incubated at 
37°C for 30 minutes. After 30 minutes of incubation this 
mixture was ready for DNA extraction. 
Wound swab samples 
Wound swab samples were collected at the QUT wound 
clinic. A total of 207 wound swabs from 38 chronic 
wound patients were included in this study using the Z-
technique. The swabs were collected over a period of 12 
weeks, when patients visited the QUT wound clinic for 
wound treatment. These samples were assigned codes to 
avoid revealing patient identity. QUT ethics approval for 
this project is included in: project approval number – 
1000001255. Non-healing (chronic) patients were 
assigned using a Pressure Ulcer Scale for Healing 
(PUSH) score, as set by the National Pressure Ulcer 
Advisory Panel (www.npaup.org/wp-
content/uploads/2012/02/push3.pdf). Patients with a 
PUSH score of more than 2 at the 24
th 
week were 
included in this study. Wound swabs were stored at -
80°C, until further use.  
DNA extraction 
DNA extraction from skin, septicemia patient isolates and 
chronic wound patient swab samples was done using the 
DNeasy® Blood and Tissue Kit (QIAGEN®, Australia) 
using the protocol described by Price and coworkers with 
modifications which involved both physical and 
enzymatic lysis steps.
41
 Briefly, frozen wound swabs 
were allowed to thaw at room temperature and suspended 
in 300µl of Ultra-pure DNAse- RNAse free water 
(Roche, Australia) and 50ul of lytic enzyme mix. A lytic 
enzyme mix was prepared fresh at the time of extraction 
and consists of 40µl/ml of Lysostaphin (Sigma, 
Australia), 20mg/ml of Lysozyme (Sigma, Australia) and 
100U/ml of Mutanolysin (Sigma, Australia). Samples 
were digested by incubating for 30 minutes at 37°C in a 
dry heating block. After centrifugation at 1500 rpm for 1 
minute, the solution was transferred into a bead-beating 
tube (MoBio, Carlsbad, CA). Bead beating (Mini-
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Beadbeater-24, Biospec Products, Bartlesville, OK) was 
carried out at 1500 rpm for 1 minute flowed by 
centrifugation at 1200 rpm for 1 minute. The crude lysate 
was transferred to a sterile microfuge tube containing 
Qiagen Buffer AL (Qiagen, Australia) and vortexed for 
15 seconds. This was followed by 10 minute incubation 
at 56
0
C and centrifugation at 1500rpm for 1 minute. After 
this step, further DNA purification was done using the 
QIAmp DNA purification kit using blood or body fluids 
protocol (spin protocol) as per manufacturer’s 
instructions (Qiagen, Australia). The extracted genomic 
DNA quality and quantity was measured using the 
NanoDrop Spectophotometer (Biolab, Australia) and the 
DNA was stored at -80
0
C until further use. For skin and 
septicaemia patient isolates, protocol for gram-positive 
bacteria as per manufacturer’s instructions (Qiagen, 
Australia) was followed and extracted DNA was stored at 
-80°C.  
Primers and PCR cycling conditions 
For the detection of the ica operon in hospital 
(septicaemia patients) and skin samples primers listed in 
Table 1 were used.
42,43
 Primers were obtained from 
Sigma-Aldrich®, Australia. Conventional PCR was 
performed on all isolates from patients and healthy 
individuals. This was followed by agarose gel (2 %) 
electrophoresis. A 100 bp DNA molecular weight marker 
(Bioline®, Australia) was used for comparison and 
analysis (Table 1). 
Table 1: Primer sequences for ica genes. 
Primers Sequence (From 5’ to 3’) Product (bp) 
icaA 
forward 
icaA 
reverse 
GAC CTC GAA GTC 
AAT AGA GGT 
CCC AGT ATA ACG 
TTG GAT ACC 
814 
icaB 
forward 
icaB 
reverse 
ATG GCT TAA AGC 
ACA CGA CGC 
TAT CGG CAT CTG 
GTG TGA CAG 
526 
icaC 
forward 
icaC 
reverse 
ATA AAC TTG AAT 
TAG TGT ATT 
ATA TAT AAA ACT 
CTC TTA ACA 
989 
icaD 
forward 
icaD 
reverse 
AGG CAA TAT CCA 
ACG GTA A 
GTC ACG ACC TTT 
CTT ATA TT 
371 
For each reaction 1µl for each of forward and reverse 
primers was mixed with 5µl of MyTaq Red Buffer and 
1µl of MyTaq HS Polymerase. 2µl of DNA template and 
DNAse/RNAse free water was then added to make a total 
reaction volume of 25µl. No addition of dNTPs and 
loading dye (for gel electrophoresis) is required as the 5 x 
MyTaq Red Buffer contains both dNTPs and loading dye. 
No addition of dNTPs is required as the 5xMyTaq Red 
Buffer contains dNTPs. No loading dye is required for 
gel electrophoresis as this is also included in the 5 x 
MyTaq Red Buffer. Each sample was amplified using a 
PCR cycling procedure as follows: 95°C for 3 minutes, 
followed by 30 cycles of 94°C for 30 seconds, 57°C 
(icaA) /65°C (icaB)/ 43°C (icaC) /65°C (icaD) for 30 
seconds and 72 °C for 10 minutes. These PCR reactions 
were run on a Mastercycler PCR engine (Eppendorf®, 
Australia). 
A 2 % agarose gel was used for electrophoresis, with a 
Tris-Borate-EDTA (TBE) running buffer. A 100 bp DNA 
molecular weight marker (Bioline®, Australia) was used 
for analysis. Figure 1 depicts the icaD detection as an 
example (Figure 1). 
 
 
Figure 1: A 2% agarose gel showing the presence of 
the icaD gene in two S. epidermidis isolates. 
For wound samples, Real-Time PCR was performed. For 
icaA and icaC, primers were designed using the Primer 
Express software (Applied Biosystems, USA). See Table 
2 below for details. For icaB and icaD same primers 
designed for testing skin and blood samples were used 
(Table 1). The Rotor-Gene 6000 instrument was used for 
RT-PCR experiments (QIAGEN, Australia) (Table 2). 
Table 2: Primer sequences for ica gene detection in 
wound samples. 
Primers Sequence (From 5’ to 3’) Product (bp) 
icaA 
forward 
icaA 
reverse 
GTC ATT GAT GAC 
GAT GCG CC 
CTT GAG CCC ATC 
GAA CCC TT 
397 
icaC 
forward 
icaC 
reverse 
ATC GCT GTT TCC 
GGT AGT GAT 
CTC TTA ACA TCA 
TTC CGA CGC C 
297 
For each reaction 1.25µl of each forward and reverse 
primer was added to 10µl of Sybr Green mastermix (Life 
Technologies, Australia) and 5.5µl of DNAse/RNAse 
100bp DNA molecular 
weight marker Positive sample 
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free water (Roche, Australia). 2 µl of DNA extract was 
added to a total reaction volume of 20µl. 
Each reaction was amplified using a three step Real-Time 
PCR cycling procedure as follows: Hold for 2 minutes at 
50°C, then at 95°C for 10 minutes, followed by 40 cycles 
of 95°C for 10 seconds, a specific annealing temperature 
for each primer (57°C (icaA) /65°C (icaB)/ 43°C (icaC) 
/65°C (icaD)) for 20 seconds and 72°C for 30 seconds. 
After the 40 PCR cycles, the DNA amplicons were 
subjected to a hold at 72°C for 5 minutes and followed by 
a melt step ramping from 72°C to 95°C rising by 1°C and 
waiting for 90 seconds for pre-melt conditioning on the 
first step only, followed by a 5 second wait for each step 
thereafter. Following the melt step, a High Resolution 
Melt (HRM) step was performed by ramping from 50°C 
to 99°C, rising by 0.1°C at each step, waiting for 90 
seconds for pre-melt conditioning on the first step only, 
followed by a 2 second wait for each step thereafter. The 
Rotor-Gene 6000 instrument was used for all experiments 
(Corbett Life Science, now QIAGEN, Australia). Two 
reference strains of S. epidermidis, the ATCC 35984 
(biofilm-producing) and the ATCC 12228 (non-biofilm-
producing) were used for RT-PCR analysis as positive 
and negative control respectively. 
RESULTS 
Different studies have reported the presence of 
Staphylococcus sp., Pseudomonas sp., Anaerococcus sp., 
Enterococcus sp., Finegoldia sp., Proteus sp., Prevotella 
sp., Stenotrophomonas sp., Citrobacter sp. Serratia sp. 
and Enterobacter sp. residing in wound beds.
26,44,45 
Based 
on the prevalence of staphylococci as the most abundant 
genera in previous studies mentioned above, as well as 
our bacterial diversity results (unpublished data) and the 
importance of S. epidermidis biofilm producing genes, 
we decided to determine the presence of ica genes in 
wound samples and compare it to blood and skin 
samples.  
The presence of the ica genes plays an important role in 
the pathogenicity of S. epidermidis and other CoNS and 
are involved in the production and expression of various 
structures such as PIA, biofilm and autolysin.
46,47 
In total, 
296 samples were tested for the presence of the ica genes 
(ADBC). Of these, 48 samples (in the form of bacterial 
cultures) were from patients with septicaemia, 41 samples 
were cultured from the skin of healthy individuals 
whereas the remaining 207 swab samples were obtained 
from chronic wound patients.  
Amongst the septicaemia patient isolates, 25% tested 
positive for the presence of icaA, 20.83 % for icaB, 33.33 
% for icaC and 29.16% for icaD. From the 41 skin 
isolates, the same percentage of icaA, icaB and icaD 
genes i.e. 19.51% was detected while 24.39% had the 
icaC gene present. Finally, 3.38% of wound samples had 
icaA, 2.41% had icaC and 4.34% had icaD while icaB 
was not detected in these samples. Figure 2 depicts a 
comparison of samples from all the sources in terms of 
various ica gene positivities (Figure 2). 
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Figure 2: Prevalence of the four ica genes in skin, 
blood and wound samples. 
Table 3 shows the number of samples that tested positive 
for each of the four ica genes in all three sample sources 
(Table 3). 
Table 3: Comparison of ica genes present in skin, 
blood and wound samples. 
Biofilm 
gene 
 
Skin 
Samples 
Blood 
Samples 
Wound 
Samples 
icaA 
Presence 8 12 7 
Absence 33 36 200 
Total  41 48 207 
icaB 
Presence 8 10 0 
Absence 33 36 207 
Total  41 48 207 
icaC 
Presence 10 16 5 
Absence 31 32 202 
Total  41 48 207 
icaD  
Presence 8 14 9 
Absence 33 34 198 
Total 41 48 207 
The interpretations are as follows: 
All four genes are present in almost the same percentages 
in both skin and blood samples indicating that the same 
genes are present in healthy skin samples and septicaemia 
patient blood samples. It could be interpreted that ica 
containing strains of bacteria which are usually present 
on the skin of healthy people are possibly involved in 
septicaemia in patients with indwelling devices.  
Furthermore, we tested wound samples for the presence 
of these genes. A very small number of these samples 
tested positive for the presence of the ica genes. It could 
be interpreted that the ica containing bacterial strains are 
not present in the wound bed in a significant number of 
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patients although, as described above, this is the opposite 
for septicaemia patients.  
DISCUSSION 
This is one of the pioneer studies reporting S. epidermidis 
ica gene detection in chronic wound samples. We have 
found that these genes are present in a significant number 
in skin samples indicating that as a part of normal skin 
flora S. epidermidis still possesses these genes. Then we 
have found a significant number of septicaemia patients 
with ica positive S. epidermidis in their blood. This is 
indicative of the involvement of these bacteria in 
septicaemia as an opportunistic pathogen. The 
mechanism in this case is most likely colonization of 
indwelling devices such as cannulas and catheters in 
these hospitalized patients with subsequent spread of 
infection to the blood stream.  
We detected a very low percentage of these genes in 
chronic wound swab samples compared to skin and blood 
samples. We propose that ica positive S. epidermidis is 
not a major species present on chronic wounds which 
could cause biofilm formation. Thus we are suggesting 
further investigating the presence of other biofilm 
producing bacterial species. Our results indicate that S. 
epidermidis strains harbouring the ica genes, is not 
present in large percentages in chronic wounds. 
There are other biofilm producing bacteria that could be 
involved. For example, Pseudomonas species and other 
Staphylococcus species such as MRSA are well known 
for biofilm formation.
20,24,48
 Furthermore, with advanced 
molecular techniques, anaerobic bacteria are also being 
reported as an important group involved in wound 
bioburden and play a role in wound chronicity and 
produce biofilm.
48,49 
P. aeruginosa causes biofilm related 
clinical infections, for example, it causes urinary tract 
infections by growing on the surface of catheters in the 
form of biofilm. PEL, PSL and alginate polysaccharides 
are produced by P. aeruginosa which harbour the pel, psl 
and alg genes, respectively. It has been shown that PEL 
and PSL polysaccharides are involved in biofilm 
production in vitro. In vivo, either one or a combination 
of these operons control biofilm production. It is 
interesting that strains lacking these genes can still form 
biofilm in vivo through mechanisms not requiring these 
polysaccharides or genes.
48
  
Frank and colleagues have studied the effect of ten 
known anti-staphylococcal agents measuring both 
planktonic minimum inhibitory concentrations (MICs) 
and minimum biofilm eliminating concentrations 
(MBECs) against S. lugdunensis isolated from patients 
with various clinical infections.
50
 The results show 
susceptibility of planktonic bacteria to all of the agents 
while biofilm growth was resistant to high concentrations 
of the majority of these antimicrobials. This clearly 
indicates the resistance/tolerance of biofilm against 
antibiotics.
50 
Overall, wound biofilm needs further 
research and studies. There is need to precisely determine 
the bacterial species involved in biofilm production in the 
case of chronic wounds. The mechanism of interference 
of biofilm with wound healing also needs to be further 
clarified.  
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